Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2025-12-24 @ 11:46 AM
NCT ID:
NCT01949961
Eligibility Criteria:
Inclusion Criteria:
* Ischemic stroke in the anterior circulation
* Treatment within 4.5 hours after stroke onset
* Informed consent
Exclusion Criteria:
* Patients with premorbid modified Rankin Scale (mRS) score ≥3;
* Patients for whom a complete NIH Stroke Score cannot be obtained;
* Hemiplegic migraine with no arterial occlusion on baseline CT;
* Seizure at stroke onset and no visible occlusion on baseline CT;
* Intracranial haemorrhage on baseline CT;
* Clinical subarachnoid haemorrhage even if baseline CT is normal;
* Large areas of hypodense ischaemic changes on baseline CT;
* Patients with primary endovascular treatment;
* Female, pregnant or breast feeding; pericarditis; sepsis; any other serious medical illness likely to interact with treatment; confounding pre-existent neurological or psychiatric disease; unlikely to complete follow-up; any investigational drug \<14 days;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01949961
Study Brief:
Protocol Section:
NCT01949961